Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
Gilenya Cuts in Fall 2014
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 5046196"]I agree with #8, this guy is just trying to stir the pot. Gilenya, for all its troubles, is the one franchise that is doing very well in terms of ROI for NVS. Over a billion dollars and soon to be more if those new indications are approved. Yes Tec is kicking butt but a billion is still a billion.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 5046196"]I agree with #8, this guy is just trying to stir the pot. Gilenya, for all its troubles, is the one franchise that is doing very well in terms of ROI for NVS. Over a billion dollars and soon to be more if those new indications are approved. Yes Tec is kicking butt but a billion is still a billion.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
Gilenya Cuts in Fall 2014
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
Gilenya Cuts in Fall 2014
>